Nursedive logo NurseDive
NurseDive

Nursing practice questions with comprehensive rationales

Start Free

NurseDive Free Nursing Practice Question

A 23-year-old sexually active female presents with white copious discharge and itch and is diagnosed with yeast vaginitis. This condition is caused by overgrowth of which
microorganism?

A. Candida albicans

Yeast vaginitis, commonly known as a yeast infection, is typically caused by an overgrowth of Candida albicans, a type of fungus. Candida albicans overgrowth can lead to symptoms like white, thick discharge and itching in the vaginal area.

B. Lactobacillus acidophilus

Lactobacillus acidophilus is a bacterium associated with maintaining vaginal health rather than causing yeast infections.

C. Escherichia coli

Escherichia coli is a bacteria that can cause different types of infections but are not typically associated with yeast vaginitis.

D. Neisseria gonorrhoeae

Neisseria gonorrhoeae is a bacteria and does not cause yeast vaginitis despite having similar presentation such as pus discharge per vaginally.

This question is an excerpt from Nurse Dive's nursing test bank - Interprofessional Care of the Client and Family Across the Lifespan II Proctored Exam. Take the full exam now


Full Explanation

Choice A rationale: Yeast vaginitis, commonly known as a yeast infection, is typically caused by an overgrowth of Candida albicans, a type of fungus. Candida albicans overgrowth can lead to symptoms like white, thick discharge and itching in the vaginal area.

Choice B rationale: Lactobacillus acidophilus is a bacterium associated with maintaining vaginal health rather than causing yeast infections.

Choice C rationale: Escherichia coli is a bacteria that can cause different types of infections but are not typically associated with yeast vaginitis.

Choice D rationale: Neisseria gonorrhoeae is a bacteria and does not cause yeast vaginitis despite having similar presentation such as pus discharge per vaginally.


Similar Questions

QUESTION

Which is a major side effect of radioactive iodine treatment for hyperthyroidism?

A. TSH low,T3 & T4 elevated

Elevated T3 and T4 with low TSH levels are indicative of hyperthyroidism, not a side effect of radioactive iodine treatment.

B. TSH elevated, T3 & T4 low

One of the expected side effects of RAI treatment for hyperthyroidism is permanent hypothyroidism (or underactive thyroid, when the thyroid does not produce enough hormones). Elevated TSH levels with low T3 and T4 are indicative of hypothyroidism.

C. TSH,T3 & T4 low

Low TSH, T3, and T4 levels are not typical outcomes of radioactive iodine treatment; typically, the treatment leads to a decrease in T3 and T4 with increased TSH levels.

D. TSH, T4 elevated and T3 low

Elevated TSH and low T3 is major side effect of radioactive iodine treatment for hyperthyroidism. However, it does not cause elevated T4 levels.

Full Explanation

Choice A rationale: Elevated T3 and T4 with low TSH levels are indicative of hyperthyroidism, not a side effect of radioactive iodine treatment.

Choice B rationale: One of the expected side effects of RAI treatment for hyperthyroidism is permanent hypothyroidism (or underactive thyroid, when the thyroid does not produce enough hormones). Elevated TSH levels with low T3 and T4 are indicative of hypothyroidism.

Choice C rationale: Low TSH, T3, and T4 levels are not typical outcomes of radioactive iodine treatment; typically, the treatment leads to a decrease in T3 and T4 with increased TSH levels.

Choice D rationale: Elevated TSH and low T3 is major side effect of radioactive iodine treatment for hyperthyroidism. However, it does not cause elevated T4 levels.

QUESTION

You're planning your medication teaching for your patient with a UTI prescribed phenazopyridine (Pyridium). What do you include?

A. "Your urine might turn bright orange."

Phenazopyridine can cause a harmless side effect of turning urine a reddish-orange color.

B. "Don't take this drug if you're allergic to penicillin."

Phenazopyridine is not contraindicated in individuals allergic to penicillin.

C. "You need to take this antibiotic for 7 days."

Phenazopyridine is not an antibiotic; it's a medication used to relieve urinary pain. Antibiotics are prescribed separately to treat UTIs.

D. "Take this drug between meals and at bedtime."

Phenazopyridine should be taken with food or after eating to minimize stomach upset, but it doesn't need to be taken between meals or at bedtime.

Full Explanation

Choice A rationale: Phenazopyridine can cause a harmless side effect of turning urine a reddish-orange color.

Choice B rationale: Phenazopyridine is not contraindicated in individuals allergic to penicillin.

Choice C rationale: Phenazopyridine is not an antibiotic; it's a medication used to relieve urinary pain. Antibiotics are prescribed separately to treat UTIs.

Choice D rationale: Phenazopyridine should be taken with food or after eating to minimize stomach upset, but it doesn't need to be taken between meals or at bedtime.

QUESTION

Mr Ozz, a 45-year-old insulin-dependent diabetic, is admitted to the hospital with a diagnosis of pneumonia. He has been febrile since admission. His daily insulin requirement is 24 units of NPH. Every morning Albert is given NPH insulin at 0730. Meals are served at 0830, 1230, and 1830.

The nurse expects that the NPH insulin will reach its maximum effect (peak) between the hours of:

A. 1530 and 2130

This does not match the peak time of NPH insulin.

B. 1730 and 2330

This does not match the peak time of NPH insulin.

C. 1130 and 1330

This does not match the peak time of NPH insulin.

D. 1330 and 1930

This is because NPH insulin is an intermediate-acting insulin that has an onset of action of 1 to 2 hours, a peak of 6 to 12 hours, and a duration of 18 to 24 hours. Therefore, if Albert is given NPH insulin at 0730, the peak effect will occur between 1330 and 1930, which means that his blood glucose level will be lowest during this time.

Full Explanation

Choice A rationale: This does not match the peak time of NPH insulin.
Choice B rationale: This does not match the peak time of NPH insulin.
Choice C rationale: This does not match the peak time of NPH insulin.
Choice D rationale: This is because NPH insulin is an intermediate-acting insulin that has an onset of action of 1 to 2 hours, a peak of 6 to 12 hours, and a duration of 18 to 24 hours. Therefore, if Albert is given NPH insulin at 0730, the peak effect will occur between 1330 and 1930, which means that his blood glucose level will be lowest during this time.